A084

LabGenomics Stock Price

Symbol: KOSDAQ:A084650Market Cap: ₩175.9bCategory: Pharmaceuticals & Biotech

A084650 Share Price Performance

A084650 Community Fair Values

    Recent A084650 News & Updates

    No updates

    LabGenomics Co., Ltd. Key Details

    ₩87.9b

    Revenue

    ₩55.7b

    Cost of Revenue

    ₩32.2b

    Gross Profit

    ₩52.4b

    Other Expenses

    -₩20.1b

    Earnings

    Last Reported Earnings
    Mar 31, 2025
    Next Reporting Earnings
    n/a
    Earnings per share (EPS)
    -271.21
    Gross Margin
    36.68%
    Net Profit Margin
    -22.91%
    Debt/Equity Ratio
    21.6%

    LabGenomics Co., Ltd. Competitors

     
     
     
     
     
     
     
     
     
     
     
     

    About A084650

    Founded
    2002
    Employees
    163
    CEO
    Sung Chin
    WebsiteView website
    www.labgenomics.co.kr

    LabGenomics Co., Ltd. engages in the research and development of biotechnology products in South Korea. It is also involved in the sale of diagnostic devices. The company was founded in 2002 and is based in Seongnam-si, South Korea.

    South Korean Market Performance

    • 7 Days: -2.5%
    • 3 Months: 19.7%
    • 1 Year: 13.3%
    • Year to Date: 27.4%
    Over the last 7 days, the market has dropped 2.5%, driven by a pullback of 8.3% in the Financials sector. In the last year, the market is actually up 13%. As for the next few years, earnings are expected to grow by 22% per annum. Market details ›
    This week, we’re diving deeper into the world of agentic AI. We’re zeroing in on the core technologies that make these intelligent agents actually reliably work. We explore what all this could mean for software, start-ups, and most importantly, the opportunities and risks each industry faces by adopting Agentic AI.
    Continue reading